Mesoblast (MEOBF) Depreciation & Amortization (CF) (2014 - 2023)
Mesoblast's (MEOBF) quarterly Depreciation & Amortization (CF) came in at $927000.0 in Q2 2023, down 13.45% year-over-year from $1.1 million in Q2 2022, and down 6.36% quarter-over-quarter from $990000.0 in Q1 2023.
Analysis
Mesoblast (MEOBF) Depreciation & Amortization (CF) (2014 - 2023) Analysis & Trends
Mesoblast has disclosed Depreciation & Amortization (CF) across 10 years of filings, most recently posting $927000.0 for Q2 2023.
- In Q2 2023, Depreciation & Amortization (CF) fell 13.45% year-over-year to $927000.0; the TTM figure through Dec 2024 stood at $927000.0 (down 69.12% YoY), while the FY2026 annual figure was $8.6 million, up 34.14% from the prior year.
- Depreciation & Amortization (CF) came in at $927000.0 for Q2 2023 at Mesoblast, down from $990000.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.7 million in Q1 2020 to a low of $531000.0 in Q1 2019.
- Average Depreciation & Amortization (CF) over 5 years is $1.2 million, with a median of $1.1 million recorded in 2021.
- Year-over-year, Depreciation & Amortization (CF) soared 588.76% in 2019 and slumped 59.3% in 2021.
- Over 5 years, Depreciation & Amortization (CF) stood at $1.7 million in 2019, then tumbled by 38.95% to $1.0 million in 2020, then advanced by 5.25% to $1.1 million in 2021, then fell by 1.54% to $1.1 million in 2022, then retreated by 14.56% to $927000.0 in 2023.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $927000.0 in Q2 2023, $990000.0 in Q1 2023, and $1.1 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 4.28 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 3.78 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 4.00 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 4.91 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 5.41 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 1.10 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 10.41 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 3.62 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 927,000.00 |
| Mar 31, 2023 | 990,000.00 |
| Dec 31, 2022 | 1.09 Mn |
| Sep 30, 2022 | 1.11 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | 1.11 Mn |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.09 Mn |
| Jun 30, 2021 | 1.13 Mn |
| Mar 31, 2021 | 1.08 Mn |
| Dec 31, 2020 | 1.05 Mn |
| Sep 30, 2020 | 1.01 Mn |
| Mar 31, 2020 | 2.66 Mn |
| Dec 31, 2019 | 1.72 Mn |
| Sep 30, 2019 | 849,000.00 |
| Mar 31, 2019 | 531,000.00 |
| Dec 31, 2018 | 249,000.00 |
| Sep 30, 2018 | 554,000.00 |
| Jun 30, 2018 | 586,000.00 |
| Mar 31, 2018 | 832,000.00 |